Co-diagnostics, inc. and cosara diagnostics to inaugurate new oligo facility

New oligonucleotide facility is designed to support "make in india" initiative by synthesizing co-primers® in-house. attendees of new ribbon-cutting event expected to include representatives from ngos and government leaders salt lake city , dec. 10, 2024 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the inauguration of cosara diagnostics pvt.
CODX Ratings Summary
CODX Quant Ranking